Gentamicin/BSA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Gentamicin (HY-A0276A) and BSA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases[1].

Gentamicin/OVA is one of protein/peptide and small molecule drug conjugates (PDCs), consisting of Gentamicin (HY-A0276A) and OVA. PCDs are promising targeted therapeutics with better cell permeability and drug selectivity than antibody-drug conjugates (ADCs). PDCs have been widely used in research on cancer, COVID-19, and metabolic diseases[1].

GePhos1, a EGFR-targeting PhosTAC (phosphorylation targeting chimera), induces EGFR dephosphorylation. GePhos1 induces apoptosis[1].

Geraniol-d6 is deuterated labeled Geraniol.

GET1 Human Pre-designed siRNA Set A contains three designed siRNAs for GET1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GET3 Human Pre-designed siRNA Set A contains three designed siRNAs for GET3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GET4 Human Pre-designed siRNA Set A contains three designed siRNAs for GET4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFAP Human Pre-designed siRNA Set A contains three designed siRNAs for GFAP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFER Human Pre-designed siRNA Set A contains three designed siRNAs for GFER gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFI1 Human Pre-designed siRNA Set A contains three designed siRNAs for GFI1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFI1B Human Pre-designed siRNA Set A contains three designed siRNAs for GFI1B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFM1 Human Pre-designed siRNA Set A contains three designed siRNAs for GFM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFM2 Human Pre-designed siRNA Set A contains three designed siRNAs for GFM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFOD1 Human Pre-designed siRNA Set A contains three designed siRNAs for GFOD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFOD2 Human Pre-designed siRNA Set A contains three designed siRNAs for GFOD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFPT1 Human Pre-designed siRNA Set A contains three designed siRNAs for GFPT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFPT2 Human Pre-designed siRNA Set A contains three designed siRNAs for GFPT2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFRA1 Human Pre-designed siRNA Set A contains three designed siRNAs for GFRA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFRA2 Human Pre-designed siRNA Set A contains three designed siRNAs for GFRA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFRA3 Human Pre-designed siRNA Set A contains three designed siRNAs for GFRA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFRA4 Human Pre-designed siRNA Set A contains three designed siRNAs for GFRA4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFRAL Human Pre-designed siRNA Set A contains three designed siRNAs for GFRAL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFUS Human Pre-designed siRNA Set A contains three designed siRNAs for GFUS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GFY Human Pre-designed siRNA Set A contains three designed siRNAs for GFY gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGA1 Human Pre-designed siRNA Set A contains three designed siRNAs for GGA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGA2 Human Pre-designed siRNA Set A contains three designed siRNAs for GGA2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGA3 Human Pre-designed siRNA Set A contains three designed siRNAs for GGA3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGACT Human Pre-designed siRNA Set A contains three designed siRNAs for GGACT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGCT Human Pre-designed siRNA Set A contains three designed siRNAs for GGCT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGCX Human Pre-designed siRNA Set A contains three designed siRNAs for GGCX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGDPS-IN-1 (Compound 37) is a geranylgeranyl diphosphate synthase (GGDPS) inhibitor with an IC50 of 49.4 nM. GGDPS-IN-1 disrupts protein geranylgeranylation in myeloma cells[1].

GGH Human Pre-designed siRNA Set A contains three designed siRNAs for GGH gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGN Human Pre-designed siRNA Set A contains three designed siRNAs for GGN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGNBP2 Human Pre-designed siRNA Set A contains three designed siRNAs for GGNBP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGPS1 Human Pre-designed siRNA Set A contains three designed siRNAs for GGPS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGT1 Human Pre-designed siRNA Set A contains three designed siRNAs for GGT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGT5 Human Pre-designed siRNA Set A contains three designed siRNAs for GGT5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGT6 Human Pre-designed siRNA Set A contains three designed siRNAs for GGT6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGT7 Human Pre-designed siRNA Set A contains three designed siRNAs for GGT7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GGTA1 Human Pre-designed siRNA Set A contains three designed siRNAs for GGTA1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GH1 Human Pre-designed siRNA Set A contains three designed siRNAs for GH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GH2 Human Pre-designed siRNA Set A contains three designed siRNAs for GH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GHDC Human Pre-designed siRNA Set A contains three designed siRNAs for GHDC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GHITM Human Pre-designed siRNA Set A contains three designed siRNAs for GHITM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GHR Human Pre-designed siRNA Set A contains three designed siRNAs for GHR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.